EPP

Clinical trials for EPP explained in plain language.

Never miss a new study

Get alerted when new EPP trials appear

Sign up with your email to follow new studies for EPP, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New drug may let people with rare sun allergy enjoy the outdoors longer

Symptom relief Completed

This study tested a drug called MT-7117 in 184 people aged 12 to 75 with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP), rare conditions that cause severe pain from sunlight. The goal was to see if the drug could delay the first signs of sun sensitivity (bur…

Matched conditions: EPP

Phase: PHASE3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Symptom relief

Last updated Jun 27, 2026 08:07 UTC

EPP

Get alerted when new EPP trials appear

New drug may let people with rare sun allergy enjoy the outdoors longer